Repeat prostate biopsies predict location of index cancer in an active surveillance cohort

BJU International

Volumn 108, Issue 9, 2011, Pages 1415-1420

  Tseng, Kenneth S ^a   Landis, Patricia ^a   Brimo, Fadi ^a   Partin, Alan W ^a   Epstein, Jonathan I ^a   Carter, H Ballentine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

active surveillance; prostate cancer; TRUS guided biopsies

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GLEASON SCORE; HUMAN; INDEX CANCER; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REPEAT BIOPSY; REPEAT PROCEDURE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; DISEASE PROGRESSION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80054993911     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10176.x     Document Type: Article

References (15)

1. Bulbul MA, El-Hout Y, Haddad M, et al,. Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer. Can Urol Assoc J 2007; 1: 264-6
2. Gregori A, Vieweg J, Dahm P, Paulson DF,. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int 2001; 66: 66-71 (Pubitemid 32172970)
3. Carter HB, Kettermann A, Warlick C, et al,. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 2007; 178: 2359-64; discussion 2364- 5
4. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-74 (Pubitemid 24037911)
5. Eggener SE, Scardino PT, Carroll PR, et al,. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178: 2260-7 (Pubitemid 350052204)
6. Stamey TA, McNeal JM, Wise AM, Clayton JL,. Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy. Eur Urol 2001; 39 (Suppl. 4): 22-3 (Pubitemid 32429649)
7. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ,. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110: 906-10 (Pubitemid 47257670)
8. Quann P, Jarrard DF, Huang W,. Current prostate biopsy protocols cannot reliably identify patients for focal therapy: correlation of low-risk prostate cancer on biopsy with radical prostatectomy findings. Int J Clin Exp Pathol 2010; 3: 401-7
9. Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS,. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009; 104: 195-9
10. Schulte RT, Wood DP, Daignault S, Shah RB, Wei JT,. Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy. Cancer 2008; 113: 1559-65
11. Scales CD Jr, Presti JC Jr, Kane CJ, et al,. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy-results from the SEARCH database. J Urol 2007; 178: 1249-52 (Pubitemid 47376716)
12. Tsivian M, Moreira DM, Sun L, et al,. Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight. Urol Oncol 2010; Epub ahead of print [in press]
13. Polascik TJ, Mayes JM, Schroeck FR, et al,. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer 2009; 15: 2104-10
14. Tsivian M, Kimura M, Sun L, Mouraviev V, Mayes JM, Polascik TJ,. Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended. BJU Int 2009; Epub ahead of print [in press]
15. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M,. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; Epub ahead of print [in press]